RareWays is a research directory. It helps you understand the science. It is not medical advice. Always discuss your care options with your healthcare team.

Coverage: 2020-01-01 onwards, with up to 300 results per query from PubMed and Europe PMC and separate limits on other sources. This is a selected index, not a complete literature search.

Updates are delayed or unverified. Check original sources for the latest information.

Your saved research and appointment questions

View recorded trial and retraction changes

ICD C64ORPHA:654

Nephroblastoma

Nephroblastoma, also called Wilms tumour, is a rare cancer of the kidney that mostly affects young children. It develops from immature kidney cells and often appears as a painless lump or swelling in the abdomen. Treatment usually combines surgery, chemotherapy and sometimes radiotherapy, and most children are cured with modern treatment.

This overview is general information, not an individual medical assessment. Research is selected automatically and may include mismatches. How we select and explain research.

407
Articles
78
Trials (13 AU)
Data refreshed
20 October 2026
Loading...

Common Questions

What is Nephroblastoma?

Nephroblastoma, also called Wilms tumour, is a rare cancer of the kidney that mostly affects young children. It develops from immature kidney cells and often appears as a painless lump or swelling in the abdomen. Treatment usually combines surgery, chemotherapy and sometimes radiotherapy, and most children are cured with modern treatment.

How many clinical trials are available for Nephroblastoma?

RareWays currently indexes 78 clinical trials for Nephroblastoma, of which 17 are actively recruiting. These counts cover indexed trials across countries, not just your country. An Australian site does not necessarily mean that site is recruiting. Check locations, eligibility and current availability with the study team.

Where does the research data for Nephroblastoma come from?

RareWays aggregates research from PubMed, Europe PMC, OpenAlex, and ClinicalTrials.gov. Data is refreshed automatically every day. All articles and trials link directly to their original sources.

Get research updates

Monthly email when new findings are published for Nephroblastoma.

Your email and selected disease are stored for these updates. Unsubscribe any time. Privacy and deletion.

This information is for general awareness only.

For guidance specific to your situation, please speak with your healthcare team.